...
机译:一项II期随机对照试验,比较了序贯和并发的紫杉醇与口服或肠胃外氟化嘧啶类药物治疗晚期或转移性胃癌的比较
Department of Surgery, Osaka General Medical Center, 3-1-56 Bandai-higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan;
Department of Biostatistics and Epidemiology, Yokohama City University, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan;
Department of Gastroenterological Surgery, Aichi Cancer Center, Aichi Hospital, 18 Kuriyado, Kakemachi, Okazaki, 444-0011, Japan;
Department of Human Health and Medical Sciences, Kochi Medical School, Kohasu-Okocho, Nankoku, Kochi, 783-8505, Japan;
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan;
Department of Surgery, Matsuyama Red Cross Hospital, 1 Bunkyomachi, Matsuyama, Ehime, 790-8524, Japan;
Department of Surgery, Saga Prefectural Hospital Koseikan, 1-12-9 Mizugae, Saga, 840-8571, Japan;
Epidemiological and Clinical Research Information Ne;
Advanced gastric cancer; Paclitaxel; S-1; Sequential chemotherapy; Concurrent combination chemotherapy; Randomized phase-II trial;
机译:一项II期随机对照试验,比较了序贯和并发的紫杉醇与口服或肠胃外氟化嘧啶类药物治疗晚期或转移性胃癌的比较
机译:术后口服佐剂口服氟嘧啶与序贯紫杉醇/口服氟嘧啶的III期随机试验;和UFT与S1联合治疗T3 / T4胃癌:胃癌佐剂多机构试验组(Samit)试验
机译:转移性或复发性乳腺癌女性口服氟代嘧啶(卡培他滨与S-1)的随机研究:日本乳腺癌研究网络05试用
机译:I / II期临床试验关于每周紫杉醇(WPTX)和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
机译:比较多种适应性干预措施的顺序多重分配随机试验的设计与分析
机译:口服卡培他滨(Xeloda®)与紫杉醇在蒽环类抗生素预处理的转移性/晚期乳腺癌患者中进行比较的随机II期试验
机译:口服卡培他滨(Xeloda®)与紫杉醇在蒽环类抗生素预处理的转移性/晚期乳腺癌患者中进行比较的随机II期试验